Posted on 5/1/19
Mustang Bio Prices Public Offering of Common Stock
NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and . . .
Posted on 4/30/19
Merck Announces First-Quarter 2019 Financial Results
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2019.“Our strong start to . . .
Posted on 4/30/19
Rocket Pharmaceuticals Receives Funding from the California Institute for Regenerative Medicine
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading U.S.-based multi-platform clinical-stage gene therapy company
Posted on 4/30/19
Vividion Therapeutics Raises $82M
Vividion Therapeutics, a biotechnology company with a revolutionary platform to discover small molecule therapeutics against biologically compelling but previously intractable targets
Posted on 4/30/19
BeyondSpring Provides Business Update
NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced its financial . . .
Posted on 4/30/19
Celgene's Final Earnings Report?
As it prepares to be acquired by Bristol-Myers Squibb (NYSE:BMY), Celgene(NASDAQ:CELG) continued its solid performance, racking up double-digit sales growth in the first quarter.Celgene results: The . . .
Posted on 4/30/19
Johnson & Johnson Comes Out Of Gate With First Approval For Targeted Bladder Cancer Therapy
Johnson & Johnson (JNJ) has made substantial groundbreaking news, because it was the first to receive FDA approval for metastatic bladder cancer that deals with specific . . .
Posted on 4/29/19
CIT Leads $425 Million Senior Credit Facility for AdaptHealth
CIT Group Inc. (NYSE: CIT) today announced that its Healthcare Finance business led a $425 million senior credit facility on behalf of AdaptHealth LLC – the . . .
Posted on 4/29/19
Vigene Biosciences Secures Institutional Investment in New Round of Growth Capital Financing
Vigene Biosciences, Inc a leading provider of viral vector products and services used in gene therapy, has completed a substantial growth capital financing transaction. The investment was . . .
Posted on 4/29/19
Better Buy: Pfizer vs. AbbVie
Pfizer (NYSE:PFE) and AbbVie (NYSE:ABBV) rank as two of the largest and most successful drugmakers on the planet. The two companies are leaders in therapeutic areas . . .
Posted on 4/29/19
Why Paragon Bioservices’ $1.2B Acquisition Deal Matters to Baltimore
On a Thursday in mid-April, Gov. Larry Hogan and other state and county officials joined biotech community supporters
Posted on 4/29/19
Precipio Takes Final Step Towards Regaining Nasdaq Compliance
NEW HAVEN, Conn., April 26, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.(NASDAQ: PRPO) today announced that it has implemented a 1-for-15 reverse stock . . .
Posted on 4/26/19
Bristol-Myers Squibb Co (BMY) Q1 2019 Earnings Call Transcript
IMAGE SOURCE: THE MOTLEY FOOL.Bristol-Myers Squibb Co (NYSE:BMY)Q1 2019 Earnings CallApril 25, 2019, 10:30 a.m. ETContents: Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood day, and welcome to . . .
Posted on 4/26/19
Pinnacle Treatment Centers Opens Additional Opioid Treatment Facility in New Jersey
VINELAND, N.J.--(BUSINESS WIRE)--Pinnacle Treatment Centers (PTC), a leader in providing accessible treatment for adult men and women struggling with substance use disorders, has opened Vineland Treatment . . .
Posted on 4/26/19
Diagnostics Manufacturing Facility Launches in India
New York City, April 25, 2019 (GLOBE NEWSWIRE) -- The long-awaited molecular diagnostics manufacturing facility for the Indian joint venture between Co-Diagnostics Inc. and Synbiotics Pvt Ltd . . .
Posted on 4/26/19
ContraVir Pharmaceuticals Prices $2.14 Million Public Offering
EDISON, N.J., April 25, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of . . .
Posted on 4/25/19
Salix Enters Into Exclusive License Agreement With Mitsubishi Tanabe Pharma
Salix Pharmaceuticals, one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases, and a wholly owned subsidiary . . .
Posted on 4/25/19
BioLabs@NYULangone Welcomes MEND as Newest Resident
NEW YORK--(BUSINESS WIRE)--BioLabs@NYULangone today announced that MEND, a company developing nutritional interventions to enhance patient outcomes across a range of conditions, has been selected as the . . .
Posted on 4/25/19
Varsity Healthcare Partners Completes Partnership with Angels of Care
STAMFORD, Conn. & LOS ANGELES--(BUSINESS WIRE)--Varsity Healthcare Partners, a leading lower middle-market private equity firm focused on healthcare services, announced today the completion of a growth . . .
Posted on 4/24/19
MAM Learn to Brush Set Named 2019 JPMA Innovation Award Winner
MAM, the leading designer brand of award-winning, medically sound and innovative baby products, today announced its Learn to Brush Set was named a Juvenile Products Manufacturers . . .
Posted on 4/24/19
Integra LifeSciences Reports First Quarter 2019 Financial Results
PLAINSBORO, N.J., April 24, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the . . .
Posted on 4/24/19
Things To Consider Before Buying Johnson & Johnson At $140
(Source: YCharts)SummaryJohnson & Johnson appears undervalued because its 16X P/E is below its historical norms.However, the business has evolved where an added presence from pharmaceuticals has . . .
Posted on 4/24/19
Why Quest Diagnostics Stock Jumped Today
What happenedShares of Quest Diagnostics (NYSE:DGX) were 9.9% higher as of 3:36 p.m. EDT on Tuesday. The diagnostic information services company announced better-than-expected first-quarter results before . . .
Posted on 4/24/19
Quest Diagnostics Beats Expectations in Q1
Quest Diagnostics (NYSE:DGX) reported a deteriorating financial performance when it announced its fourth-quarter results in February. Revenue fell by 1.4% year over year while earnings dropped . . .
Posted on 4/23/19
PrimeRx Named 2019 Pharmacy Software Company of the Year
Micro Merchant Systems through its PrimeRx pharmacy management system has been named "2019 Software Company of the Year" by the American Pharmacy Purchasing Alliance (APPA).The award, . . .

